Researchers
Aleksić, Dejan
Results 1-20 of 64
| Issue Date | Title | Author(s) | Type | Мp-cat. |
|---|---|---|---|---|
| 2026 | Beyond relapse control: motor and cognitive subclinical progression in RRMS -a real-world longitudinal study of ocrelizumab and interferon beta | Todorovic, Stefan; Vojinovic, Slobodan; Savic, Dejan; Danilovic, Milos; Aleksic, Dejan Z | Article | 22M22 |
| 2025 | Sporadic inclusion body myositis: Single center case series of 8 patients from a fifteen-year period![]() | Aleksić, Dejan | Article | 53M53 |
| 2025 | Relationship Between Physical Fitness Index and Body Mass Index: A Cross-Sectional Study in Serbian Students of Biomedical Sciences![]() | Ajdinović, Aldina | Article | 21M21 |
| 2025 | Can leukotriene receptor inhibitors preserve cognitive functions in asthma patients? | Aleksić, Dejan | Article | 51M51 |
| 2024 | Successful Treatment Response in a Patient with Severe Neurological Manifestations of Drug-Induced Acute Intermittent Porphyria: A Case Report | Todorovic, Stefan; Dordevic, Gordana; Rancic, Andrija; Aleksic, Dejan Z | Article | 22M22 |
| 2023 | The impact of the comorbid seizure/epilepsy on the health related quality of life in people with multiple sclerosis: an international multicentric study![]() | Drulović, Jelena S. | Article | 21M21 |
| 2023 | Potential beneficial effect of IFN-β1a and ocrelizumab in people with MS during the COVID-19 pandemic![]() | Todorovic, Stefan; Vojinovic, Slobodan | Article | 22M22 |
| 2023 | The first case of combined oxidative phosphorylation deficiency-1 due to a GFM1 mutation in the Serbian population: a case report and literature review | Aleksic, Dejan Z | Article | 22M22 |
| 2023 | Basophilic peripheral nerve inclusions in a patient with L144F SOD1 amyotrophic lateral sclerosis![]() | Aleksić, Dejan | Article | 23M23 |
| 2023 | The Importance of Deconditioned Patient Rehabilitation after Hospital Treatment of COVID-19 Infection: A Case Report | Grbovic, Vesna | Article | 22M22 |
| 2023 | The Health Related Quality Of Life among Patients with Medication Overuse Headache: One Year University Headache Center Experience![]() | Ljubisavljevic Srdjan; Aleksic Dejan | Article | Mp. category will be shown later |
| 2023 | Satisfying outcome of vagus nerve stimulation applied in the treatment of a patient with drug-resistant epilepsy caused by periventricular nodular heterotopia | Todorovic, Stefan; Bisevac, Boban; Lukic, Stevo R; Ilic, Jovan; Aleksic, Dejan Z | Article | 23M23 |
| 2022 | The potential Drug-Drug Interactions (pDDIs) which include antimicrobials in patients with acute ischemic stroke | Aleksic, Dejan Z | Conference Paper | Mp. category will be shown later |
| 2022 | Validation of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) in a Large Cohort of Relapsing-Remitting MS Patients![]() | Drulović, Jelena | Article | 22M22 |
| 2022 | Prevalence and predictors of potentially severe drug-drug interactions in patients with myasthenia gravis![]() | Aleksić, Dejan Z. | Conference Paper | Mp. category will be shown later |
| 2022 | Potential drug-drug interactions among patients with spontaneous intracerebral hemorrhage treated at the Neurological Intensive Care Unit: a single-center experience | Aleksic, Dejan | Article | 23M23 |
| 2021 | Potential drug-drug interactions in patients with Parkinson's disease identified by Epocrates and Medscape | Aleksic, Dejan Z | Conference Paper | Mp. category will be shown later |
| 2021 | Risk factors for potential drug–drug interactions in patients with myasthenia gravis | Aleksic, Dejan | Article | 22M22 |
| 2021 | Prospective analysis of disability and quality of life in patients with chronic inflammatory demyelinating polyradiculoneuropathy![]() | Božović, Ivo | Article | 21aM21a |
| 2021 | Depression and Fatigue in Patients With Multiple Sclerosis Have No Influence on the Parameters of Cognitive Evoked Potentials![]() | Lazarevic V.; Azanjac Arsic A. | Article | 22M22 |
